Pertento reports 361,988 shares (5.2%) in Nutex Health
Rhea-AI Filing Summary
Nutex Health, Inc. ownership disclosure: Pertento Partners LLP, Pertento Advisors LLC and Eduardo Marques each report 361,988 shares of Common Stock, 5.2% of the class, as reported in the Schedule 13G. The filing states these securities are directly owned by advisory clients of Pertento Partners LLP. The reporting persons signed a Joint Filing Agreement.
Positive
- None.
Negative
- None.
Insights
Large passive stake reported by advisory entities and principal.
Pertento Partners LLP, Pertento Advisors LLC, and Eduardo Marques each report 361,988 shares (5.2%) of Common Stock. The filing lists shared voting and dispositive power of 361,988 for each reporting person.
The filing states the shares are directly owned by advisory clients; cash-flow treatment and trading intent are not disclosed. Subsequent filings may clarify whether these holdings are passive or part of coordinated activity.
Joint filing and disclaimer indicate coordinated reporting, not necessarily beneficial control.
The report includes a Joint Filing Agreement and a signed disclaimer stating each reporting person disclaims beneficial ownership except to the extent of pecuniary interest. Item 6 explains securities are owned by advisory clients of Pertento Partners LLP.
Voting/dispositive powers are reported as shared. Monitor future disclosures for any Section 13(d) activity or changes in ownership percentages.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What stake does Pertento report in Nutex Health (NUTX)?
Are these holdings reported as passive or active under Schedule 13G?
Did the reporting persons sign any agreement when filing?
AI-generated analysis. How Rhea-AI works. Not financial advice.